PTC Therapeutics Inc. buy Jefferies Financial Group Inc.
Start price
21.03.24
/
50%
€27.60
Target price
21.03.25
€32.14
Performance (%)
-14.49%
Price
26.04.24
€23.20
Summary
This prediction is currently active. The price of PTC Therapeutics Inc. has decreased since the start of the prediction. Compared to the start price this results in a performance of -14.49%. This prediction currently runs until 21.03.25. The prediction end date can be changed by Jefferies_Financial_ at any time. Jefferies_Financial_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| PTC Therapeutics Inc. | 0.000% | 0.000% |
| iShares Core DAX® | 2.594% | -1.861% |
| iShares Nasdaq 100 | 3.553% | -2.064% |
| iShares Nikkei 225® | 0.687% | -8.704% |
| iShares S&P 500 | 2.209% | -1.988% |
Comments by Jefferies_Financial_ for this prediction
In the thread PTC Therapeutics Inc. diskutieren
PTC Therapeutics, Inc. (NASDAQ: PTCT) had its price target raised by analysts at Jefferies Financial Group Inc. from $33.00 to $35.00. They now have a "buy" rating on the stock.
Ratings data for PTCT provided by MarketBeat